Northwest Biotherapeutics reported $189.9M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 128M 21M Mar/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Celldex Therapeutics USD 2.92B 809M Jun/2026
Eisai JPY 1.2T 219.32B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Northwest Biotherapeutics USD 332M 24M Mar/2026
Pfizer USD 138.44B 15.37B Jun/2026
Plus Therapeutics USD 1000K 70M Mar/2026
Roche Holding CHF 270B 3.66B Jun/2026